One of the world leaders in veterinary
medicines and vaccines

Merial is one of the world’s leading groups specialising in veterinary drugs and vaccines. The company's heritage and strength are founded on the research and development of innovative vaccines and medicines that improve the health, well-being and performance of animals.

Merial offers products and services for the prevention and treatment of diseases affecting production animals (cattle, pigs, sheep and poultry), pets (dogs, cats and horses), and wildlife (foxes and racoons). Merial provides veterinaries, livestock farmers and pet owners with a wide range of products that meet the highest standards of quality, harmlessness and efficacy.

On 1 August 1997, Merial was formed by the merger between the animal-health and poultry-genetics operations of Merck & Co., Inc. and Rhône-Poulenc S.A. (now Sanofi-Aventis).

FRANCE: (2010 figures) 4 production plants, including 3 in the Lyon region: Lyon Gerland, Lyon Porte des Alpes and Lentilly (west of Lyon)    WORLD: (2010 figures) Around 5,600 employees world

Merial is a member of the Lyon BioPôle competitiveness cluster.